IRIS - Res&Arch Institutional Research Information System - Research & Archive

DE SOCIO, GIUSEPPE VITTORIO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.008
NA - Nord America 2.527
EU - Europa 1.644
SA - Sud America 1.035
Continente sconosciuto - Info sul continente non disponibili 339
AF - Africa 110
OC - Oceania 2
Totale 8.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.378
SG - Singapore 1.199
BR - Brasile 768
VN - Vietnam 464
CN - Cina 405
IT - Italia 321
HK - Hong Kong 275
RU - Federazione Russa 253
KR - Corea 198
IE - Irlanda 194
FR - Francia 184
DE - Germania 155
SE - Svezia 141
UA - Ucraina 124
BD - Bangladesh 100
AR - Argentina 90
GB - Regno Unito 82
IN - India 70
FI - Finlandia 66
CA - Canada 63
TR - Turchia 56
MX - Messico 50
EC - Ecuador 49
ID - Indonesia 42
CO - Colombia 38
IQ - Iraq 38
VE - Venezuela 29
AT - Austria 26
ZA - Sudafrica 25
PK - Pakistan 19
JP - Giappone 18
NL - Olanda 18
PL - Polonia 18
SA - Arabia Saudita 17
UZ - Uzbekistan 17
CL - Cile 16
MA - Marocco 16
PY - Paraguay 15
PH - Filippine 14
ES - Italia 13
PE - Perù 13
EG - Egitto 12
SC - Seychelles 12
CR - Costa Rica 11
LB - Libano 11
JO - Giordania 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
KE - Kenya 7
MY - Malesia 7
RO - Romania 7
BE - Belgio 6
DZ - Algeria 6
GR - Grecia 6
UY - Uruguay 6
AL - Albania 5
JM - Giamaica 5
LT - Lituania 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
ET - Etiopia 4
GA - Gabon 4
GT - Guatemala 4
IL - Israele 4
OM - Oman 4
TH - Thailandia 4
TN - Tunisia 4
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
KZ - Kazakistan 3
SD - Sudan 3
SN - Senegal 3
AU - Australia 2
BY - Bielorussia 2
BZ - Belize 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
HN - Honduras 2
HU - Ungheria 2
ML - Mali 2
MU - Mauritius 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BT - Bhutan 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HT - Haiti 1
Totale 8.311
Salva come PNG Salva come JPEG
Città #
Singapore 796
Hong Kong 272
San Jose 226
Seoul 197
Chandler 193
Dublin 192
Ashburn 174
Ho Chi Minh City 154
Lauterbourg 128
Columbus 99
Santa Clara 99
Piscataway 97
Moscow 92
San Mateo 86
Beijing 84
New York 82
Hanoi 81
São Paulo 74
Los Angeles 72
Dong Ket 67
Boardman 63
Jacksonville 58
Perugia 58
Munich 55
Altamura 54
Medford 45
Princeton 45
Wilmington 39
Lawrence 38
Ann Arbor 33
Council Bluffs 33
Rio de Janeiro 33
Hefei 31
The Dalles 30
Dallas 26
Helsinki 26
Des Moines 25
Mexico City 23
Milan 23
Montreal 23
Buffalo 22
Nuremberg 22
Falls Church 20
Frankfurt am Main 20
Haiphong 20
Andover 17
Guayaquil 17
Tokyo 17
Chennai 16
Curitiba 16
Houston 16
Orem 16
Baghdad 15
Denver 15
Turku 15
Amsterdam 14
Florence 14
Rome 14
Toronto 14
London 13
Quito 13
Vienna 13
Warsaw 13
Brooklyn 12
Caracas 12
Medellín 12
Padova 12
Porto Alegre 12
Tashkent 12
Ankara 11
Belo Horizonte 11
Guangzhou 11
Guarulhos 11
Ninh Bình 11
Poplar 11
Riyadh 11
Bologna 10
Boston 10
Brasília 10
Falkenstein 10
Izmir 10
Norwalk 10
Phoenix 10
Salvador 10
Woodbridge 10
Atlanta 9
Campinas 9
Da Nang 9
Dhaka 9
Johannesburg 9
Manaus 9
Mersin 9
Miami 9
San José 9
Stockholm 9
Amman 8
Biên Hòa 8
Hải Dương 8
Istanbul 8
Jakarta 8
Totale 4.767
Salva come PNG Salva come JPEG
Nome #
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 169
Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. 151
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 145
Accelerate Pheno™ blood culture detection system: a literature review 134
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 130
Achromobacter denitrificans renal abscess. 125
Acute cytomegalovirus meningomyelitis in an immunocompetent patient. 124
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 116
Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli 115
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 109
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial 109
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 107
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 105
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 103
Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C 101
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 100
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 96
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 96
[Loa loa filariasis in Italy: review of the literature with a clinical report] 94
Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics. 94
Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status. 91
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 88
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 87
Early treatment with bamlanivimab alone does not prevent COVID-19 hospitalization and its post-acute sequelae. A real experience in Umbria, Italy 86
Infezioni da Cytomegalovirus nel paziente immunodepresso. 85
Prevalence of smoking and nicotine dependence in HIV patients, the project STOPS HIV from Italy 85
Smoking habits in HIV-infected people compared with the general population in Italy: A cross-sectional study 85
Decreasing cardiovascular risk in HIV infection between 2005 and 2011. 84
XVI Convegno Nazionale AIDS e SINDROMI CORRELATE 83
Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort 83
Lingual tubercolosis: a rare disease in western countries 81
Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection 79
Negative influence of HIV infection on day-night blood pressure variability. 78
An unusual case of epigastric and back pain: expanding descending thoracic aneurysm resulting from tertiary syphilis diagnosed with positron emission tomography. 78
Le infezioni da Cytomegalovirus ed il loro trattamento nel paziente immunodepresso (AIDS e TMO). 74
Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast® 72
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 70
HIV infection and antiretroviral treatment: a "two-hit" model for arterial stiffness? 69
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 67
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort 65
Fusobacterium nucleatum endocarditis mimicking polymyalgia rheumatica 65
Observed versus predicted cardiovascular events and all-cause death in HIV infection: A longitudinal cohort study 63
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 62
Laboratory automation, informatics, and artificial intelligence: current and future perspectives in clinical microbiology 61
AmBisome administration for Candida albicans shunt infections 60
Bictegravir and Dolutegravir have no impact on glucose levels 12 months after initiation 60
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 60
Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study 58
Retroperitoneal abscess: an uncommon localization of tubercular infection. 58
Real-life monocentric Biktarvy cohort from Perugia 56
Liver enzyme variation after switching to emtricitabine/tenofovir alafenamide/bictegravir is associated with glucose increase in a real-life cohort 55
Antiretroviral therapy and adverse skeletal effects 55
Giant Infective Endocarditis of Native Aortic Valve with Secondary Mitral Kissing Vegetation 54
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study 54
Thrombocytopenia in HIV infected patients: prevalence and clinical spectrum 53
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 53
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir] 53
Ageing with HIV: a multidisciplinary review 52
[Low incidence of streptococcal pharyngitis in young adults] 52
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. 51
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 50
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 50
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 50
HIV Infection - Screening, Diagnosis, and Treatment 49
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data 49
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 49
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 48
A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing 48
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 48
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 47
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 47
Knowledge of STIs and HIV among people with and without HIV: where are we now? 47
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 46
Reversibility of Central Nervous System Adverse Events in Course of Art 46
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 45
Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required 44
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 44
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 42
Adefovir induced hypophosphatemic osteomalacia 42
Schizophrenia, drug therapy, and monitoring 42
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 42
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians 42
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 41
Waist circumference and body mass index in HIV infection 41
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 40
Factors Associated With Weight Gain in People Treated With Dolutegravir 40
Safety and efficacy of switching people with HIV to dual treatment with 3TC/DTG and RPV/DTG in real life: results from the SCOLTA cohort 40
UV-C Irradiation Effectiveness on Mpox-Virus-Contaminated Surfaces 40
With or without TAF? What is the difference? Data from a real-life setting 40
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 39
Relations between cardiovascular risk estimates and subclinical atherosclerosis in naı¨ve HIV patients: results from the HERMES study 39
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project 39
Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study 38
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 38
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen 38
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? 37
[Nosocomial infections in a general surgical ward] 37
Il fumo di sigaretta, un fattore di rischio maggiore per la popolazione HIV-positiva: strategie di intervento 37
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens 36
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study 36
Totale 6.761
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022353 0 58 10 25 18 15 7 91 13 13 47 56
2022/2023675 48 130 11 54 44 83 9 23 246 0 16 11
2023/2024267 11 32 14 5 4 1 69 3 23 11 50 44
2024/20251.322 9 66 24 28 78 48 54 55 216 278 200 266
2025/20265.109 314 389 450 1.176 425 234 620 317 497 413 181 93
2026/2027332 128 204 0 0 0 0 0 0 0 0 0 0
Totale 8.665